|
|
Oligonucleotide Array Sequence Analysis
Research News and Information
Definition of 'Oligonucleotide Array Sequence Analysis'Hybridization of a nucleic acid sample to a very large set of oligonucleotide probes, which are attached to a solid support, to determine sequence or to detect variations in a gene sequence or expression or for gene mapping. Common names: Oligonucleotide Array Sequence Analysis; Oligodeoxyribonucleotide Array Sequence Analysis; Sequence Analysis, Oligonucleotide Array; DNA Microarrays; DNA Microarray; Microarray, DNA; Microarrays, DNA; DNA Arrays; Array, DNA; Arrays, DNA; DNA Array; DNA Microchips; DNA Microchip; Microchip, DNA |
Saturday, November 21, 2009
PARP1 expression in pediatric central nervous system tumors.
13 Dec 2009
BACKGROUND: Despite advances in therapy, outcome in many high-grade pediatric central nervous system (CNS) tumors remains poor. The focus of neuro-oncology research has thus turned towards identifying novel therapeutic targets. Poly(ADP-ribose) ... Read more...
29 Nov 2009
Following our recent findings on the presence of human cytomegalovirus (HCMV) in the normal human adrenal cortex and in adrenocortical tumors, especially in cortisol-secreting tumors, aim of the present study was to investigate the direct effects of ... Read more...
29 Nov 2009
The tumor suppressor role of annexin-A7 (ANXA7) was previously demonstrated by cancer susceptibility in Anxa7(+/-)-mice and by ANXA7 loss in human cancers, especially in hormone-resistant prostate tumors. To gain mechanistic insights into ANXA7 ... Read more...
Latest indexed articles for 'Oligonucleotide Array Sequence Analysis'
These are the very latest articles for this heading:
- PARP1 expression in pediatric central nervous system tumors.
13 Dec 2009 - Human cytomegalovirus productively infects adrenocortical cells and induces an early cortisol response.
29 Nov 2009 - Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
29 Nov 2009 - HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.
29 Nov 2009 - Identification of genes associated with progression and metastasis of advanced cervical cancers after radiotherapy by cDNA microarray analysis.
13 Nov 2009 - Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.
13 Nov 2009 - Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
13 Nov 2009 - Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.
13 Nov 2009 - Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
13 Nov 2009 - Cytokines decrease expression of interleukin-6 signal transducer and leptin receptor in central nervous system glia.
30 Oct 2009 - Aberrant expression of synaptic plasticity-related genes in the NF1+/- mouse hippocampus.
30 Oct 2009 - Proliferation deficits and gene expression dysregulation in Down's syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres.
30 Oct 2009 - Gene expression analysis on anterior temporal neocortex of patients with intractable epilepsy.
30 Oct 2009 - Cellular dichotomy between anchorage-independent growth responses to bFGF and TPA reflects molecular switch in commitment to carcinogenesis.
30 Oct 2009 - A dynamic oral cancer field: unraveling the underlying biology and its clinical implication.
30 Oct 2009 - Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
30 Oct 2009 - Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.
30 Oct 2009 - Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer.
30 Oct 2009 - Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.
30 Oct 2009 - Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.
30 Oct 2009
See a longer list of these articles.
Technical information about 'Oligonucleotide Array Sequence Analysis'
Definition: Hybridization of a nucleic acid sample to a very large set of oligonucleotide probes, which are attached to a solid support, to determine sequence or to detect variations in a gene sequence or expression or for gene mapping.
Descriptor UI: D020411
Alternative terms: Oligonucleotide Array Sequence Analysis; Oligodeoxyribonucleotide Array Sequence Analysis; Sequence Analysis, Oligonucleotide Array; DNA Microarrays; DNA Microarray; Microarray, DNA; Microarrays, DNA; DNA Arrays; Array, DNA; Arrays, DNA; DNA Array; DNA Microchips; DNA Microchip; Microchip, DNA; Microchips, DNA; DNA Chips; Chip, DNA; Chips, DNA; DNA Chip; Gene Expression Chips; Chip, Gene Expression; Chips, Gene Expression; Expression Chip, Gene; Expression Chips, Gene; Gene Expression Chip; Gene Chips; Chip, Gene; Chips, Gene; Gene Chip; Oligonucleotide Arrays; Array, Oligonucleotide; Arrays, Oligonucleotide; Oligonucleotide Array; Oligonucleotide Microarrays; Microarray, Oligonucleotide; Microarrays, Oligonucleotide; Oligonucleotide Microarray; Sequencing By Hybridization; Sequencing By Hybridizations; cDNA Microarrays; Microarray, cDNA; Microarrays, cDNA; cDNA Microarray; cDNA Arrays; Array, cDNA; Arrays, cDNA; cDNA Array; Microarray Analysis of Gene Expression; Gene Expression Microarray Analysis;
Related Mesh Headings: Oligonucleotide Probes; Combinatorial Chemistry Techniques; Gene Expression Profiling;
Allowable Qualifiers: classification; economics; history; instrumentation; methods; standards; trends; utilization; veterinary; statistics & numerical data; ethics;
Tree Number: E05.196.630.570.660; E05.393.525.640; E05.393.661.640; E05.393.760.640; E05.588.570.660; E05.601.640;
History Note: 99
Technical Notes: coord with GENE EXPRESSION PROFILING if pertinent